SCHEMBL4351555

SCHEMBL4351555

CC(C)(C)c1ccc(C=CC=C2SC(NCc3ccc4c(c3)OCO4)=NC2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.43
TRPV1 Q8NER1 2/20 0.42
DOT1L Q8TEK3 1/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
KMT2A Q03164 3/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
MTOR P42345 1/20 0.36
GALR3 O60755 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PDE9A O76083 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355546 0.80 HPGD (0.43) TRPV1HDAC3HDAC1HDAC2HDAC6
SCHEMBL4355549 0.80 HPGD (0.43) TRPV1HDAC3HDAC1HDAC2HDAC6
SCHEMBL4350119 0.74 HPGD (0.48) MAPK1KMT2ARAB9AMEN1SMN1; SMN2
SCHEMBL4350122 0.74 HPGD (0.48) MAPK1KMT2ARAB9AMEN1SMN1; SMN2
SCHEMBL4873444 0.73 CLK4 (0.45) MAPK1KMT2ARAB9AMEN1ALDH1A1
SCHEMBL4351083 0.71 ALDH1A1 (0.42) MAPK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL4355388 0.70 KDM4E (0.47) MAPK1KMT2ARAB9AMEN1SMN1; SMN2
SCHEMBL4355386 0.70 KDM4E (0.47) MAPK1KMT2ARAB9AMEN1SMN1; SMN2
SCHEMBL4359358 0.68 ALOX5 (0.44) HDAC3HDAC1HDAC2KMT2ARAB9A
SCHEMBL4352430 0.67 ALOX5 (0.47) MAPK1TRPV1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MAPK1 3105/4885TRPV1 694/4885DOT1L 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.